ROIV
Roivant Sciences Ltd
35.50$
-2.9%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| – | +2,812.6% | -64.8% | +132.3% | -43.0% | +3.8% | -11.2% | -71.6% | |
| – | +86.6% | +81.9% | +335.9% | -66.2% | -47.3% | -43.0% | +41.1% | |
| – | +3,774.2% | -67.3% | +113.1% | -38.5% | +9.2% | -9.6% | -75.2% | |
| – | -48.7% | -10.1% | +104.1% | -6.0% | -3.1% | +25.1% | +23.9% | |
| – | +41.5% | -22.6% | +198.2% | -50.5% | +8.5% | +42.1% | +3.2% | |
| – | -20.2% | +82.4% | +15.1% | -33.4% | +2.2% | +33.4% | +13.2% | |
| – | – | – | – | – | – | – | – | |
| – | +2.0% | -63.4% | +150.7% | +297.2% | +24.3% | – | – | |
| – | – | – | – | – | – | -114.9% | – | |
| – | +171.5% | -76.3% | -78.1% | +1,006.2% | +426.8% | +124.0% | +176.8% | |
| – | – | -167.4% | – | – | – | -104.0% | – | |
| – | -500.6% | – | – | – | – | -114.4% | – |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.